SlideShare a Scribd company logo
The Computerized Symptom Capture Tool
(C-SCAT): A Novel Approach to Exploring
Symptoms and Symptom Clusters In
Adolescents and Young Adults with Cancer
Lauri Linder, PhD, APRN, CPON Catherine Fiona Macpherson, PhD, RN, CPON
University of Utah College of Nursing Seattle Children’s Hospital
Primary Children’s Hospital University of Washington
Kristin Stegenga, PhD, RN, CPON Suzanne Ameringer, PhD, RN
Children’s Mercy Hospital Virginia Commonwealth University
Jeanne Erickson, PhD, RN, AOCN Pamela Hinds, PhD, RN, FAAN
University of Virginia Children’s National Medical Center
Nancy Fugate Woods, PhD, RN, FAAN
University of Washington
Speaker Disclosure Statement
 The authors have no financial relationships to disclose
Adolescents and Young Adults with
Cancer
 Approximately 70,000 adolescents and young adults newly
diagnosed each year (National Cancer Institute, 2012)
 15 to 39 years of age (National Cancer Institute, 2012)
 Cancer types distinct from older and younger age groups
 Developmental characteristics
 Adolescents physically maturing, achieving independence from
parents, and making significant decisions related to education
and relationships
 Young adults achieving financial, residential, and emotional
independence; assuming adult roles
 Both groups with access to electronic media and often prefer
computers to paper for completing health surveys
Defining Symptom …
 “… a subjective experience reflecting changes in the
biopsychosocial functioning, sensations, or cognition of an
individual.” (Harver & Mahler, 1990)
 “The gold standard for the study of symptoms is based on
the perception of the individual experiencing the symptom
and his/her self-report.” (Dodd et al., 2001)
Symptoms in Adolescents and Young
Adults with Cancer
 Adolescents and young adults receiving treatment for
cancer report up to 12 concurrent symptoms (Baggott et al.,
2010; Collins et al., 2000; Enskar & von Essen 2008; Hedstrom et al., 2006;
Hedstrom et al., 2004; Yeh et al., 2009; Zhukovsky et al., 2009)
 Number of symptoms and associated symptom distress
greatest while receiving treatment (Collins et al., 2000; Enskar &
von Essen, 2007; Hinds et al., 2009)
 Severity of symptoms influences decision-making related
to treatment (Docherty, Sandelowski, & Preisser, 2006; Woodgate, Degner,
& Yanofsky, 2003)
What is a Symptom Cluster?
 Two or more symptoms that are related to each other
and that occur together (Kim et al., 2005)
 Relationships between the symptoms are associative and
not necessarily causal
 May share a common etiology or underlying mechanism
(Barsevick, 2007)
Hockenberry & Hooke, 2007
Why Study Symptom Clusters vs.
Individual Symptoms?
 Identifying and understanding symptom clusters…
 Informs effective symptom management interventions (Kim
et al., 2005; Miaskowski, Dodd, & Lee, 2004)
 May lead to prevention and relief of the complex and/or
synergistic effects of multiple symptoms on patient
outcomes (Kim et al., 2005; Miaskowski, Dodd, & Lee, 2004)
Symptom Clusters in Adolescents and
Young Adults with Cancer
 Symptom cluster research is limited
 Adolescents frequently included in study samples with
school-age children
 Young adults frequently included in study samples with
older adults
 Research exploring whether and how AYAs cluster
their symptoms or the meaning they attach to their
symptoms and symptom clusters is limited
Approaches to Symptom Cluster
Research
 Dominant approaches for studying symptom clusters
include multivariate statistical methods to identify
clusters from patient-reported symptoms (Baggott et al.,
2012; Hockenberry et al., 2011; Miaskowski et al., 2006; Yeh et al., 2008)
 Symptom cluster heuristics is an alternate
methodological approach that explores patients'
interpretation and meaning of the symptom cluster
experience
Aims
 Examine feasibility and acceptability of using the
Computerized Symptom Capture Assessment Tool
(C-SCAT) for exploring symptoms and symptom
clusters in AYAs with cancer
 Describe the symptoms and symptom clusters
from the perspectives of AYA with cancer
Participants
 72 AYAs receiving
myelosuppressive
chemotherapy
 40 adolescents (median 15
years; range 13-18)
 32 young adults (median 21.5
years; range 19-29)
 Median of 3 months since
diagnosis (range 1 – 156)
 57% male; 79% White/Non-
Hispanic
ALL
AML
Hodgkin
lymphoma
Non-
Hodgkin
lymphoma
Sarcoma
Brain
tumor
Other
solid
tumor
Study Procedure
 Participants completed the C-SCAT app with a study team
member present 24 to 96 hours after initiating a
chemotherapy cycle
 Participants completed a questionnaire delivered via the
iPad addressing the app’s acceptability
 Ethical considerations
 IRB approval granted from the five data collection sites
 Parental permission and participant assent obtained from
participants 13 – 17 years
 Informed consent obtained from participants 18 years and
older
Goals of the C-SCAT
 Integrate innovative and developmentally meaningful
technology in a novel approach to study symptoms and
symptom clusters in AYAs with cancer
 Elicit interpretive guidance from adolescents as to the
meaning of their symptoms and symptom clusters by allowing
the AYAs to identify:
 Symptoms, possible causes, alleviating/exacerbating factors,
attempted self-management strategies, and effects of symptoms
on daily activities
 Perceived causal and temporal relationships among symptoms
 Names for symptom clusters and key symptoms within clusters
Steps to C-SCAT Completion
 Drag and drop symptoms experienced in past 24
hours into designated area of screen
 Identify symptom cause, characteristics, attempted
self-management, and effect on daily activities
 Draw lines and arrows to indicate relationships
between symptoms
 Draw boxes around groups of related symptoms
 Identify priority symptom within each group
Results - Feasibility
 100% fully completed C-SCAT within 24 – 96 hours of
starting a new chemotherapy cycle
 Mean of 25 minutes to complete the app (SD=17; range
2 – 83)
 70% indicated final image was accurate representation
of their symptom experience
 3 cases of technical difficulties with lost/missing data
 Participants completed app with minimal questions for
clarification
Results - Acceptability
0 10 20 30 40 50 60 70 80 90 100
Acceptable amount of time to complete app
Bored while completing the app
App asked important questions
Easy to type or draw in the app
App instructions easy to follow
App questions clear or very clear
Percent of respondents in agreement
Results - Acceptability
 Increased self-awareness of symptom experience
 Appreciation for ability to create pictorial representation of
symptoms
 Preference for using technology over paper and pencil
instruments
 Familiarity with technology
 Novelty of the application
 Appreciation of speed and flexibility for editing responses
 Ease of using touchscreens rather than writing responses
 Suggestions for improvement
 Additional symptoms
 Focused questions
 More engaging color graphics
Results - Acceptability
 How did it feel to think about your symptoms while
completing the app?
 “It made me understand my own symptoms a little better,
actually”
 “It was fine. It certainly didn’t make my symptoms worse.”
 “It was kind of hard because I’ve had so many different
symptoms that I can’t remember if they happened within the
time period you asked about.”
 “Not good to [be] reminded [of] all [the] bad things.”
 “Painful”
 “Sucky”
Results - Acceptability
 83% expressed a preference for the app vs a paper-
and-pencil version
 “Doing it on paper would be boring and a lot more work to do.
And most people my age are lazy and wouldn't want to do it.”
 “It's incredible technology, there's nothing exciting about paper”
 “No erasing, and the iPad had autocorrect, and also I’m used to
typing on touchscreens.”
 “Because of my hands and neuropathy easier to do on iPad”
Results – Symptoms & Symptom Clusters
 Median of 8 symptoms
 (range 1-21)
 Most frequently reported individual symptoms
 Nausea, lack of appetite, lack of energy, feeling drowsy
 65% of AYAs identified symptom clusters
 (median 2 clusters; range 1-4)
 Cluster name examples
 “chemo effects,” “not fun treatment,” “troublesum (sic),” “crap”
Future Directions
 Refinements to the C-SCAT app
 Additional symptoms, more engaging graphics, more focused
questions
 Address technical difficulties
 Use the C-SCAT to facilitate a personalized approach
to symptom management as a mobile health resource
 Enhance adolescent-healthcare provider communication
 Prioritize symptom management interventions
Conclusion
 C-SCAT shifts paradigm of symptom and symptom cluster
assessment from deductive to inductive approach that considers
how individuals interpret and give meaning to symptoms
 C-SCAT demonstrated:
 feasibility
 acceptability
 capacity to generate rich data reflecting the individual’s experience
 C-SCAT has potential for use in clinical care to foster patient-
provider communication about complex symptom experiences to
facilitate symptom management:
 for AYAs with cancer
 across other age and disease groups
 Funding for adolescents at Primary Children’s Hospital, Seattle Children’s Hospital, and Children’s Mercy Hospital
 St. Baldrick’s Foundation Supportive Care Grant 2011-2013 (Linder, PI)
 Funding for young adults:
 Primary Children’s Hospital
 University of Utah College of Nursing Faculty Research Grant (Linder, PI);
 Seattle Children’s Hospital
 Seattle Children’s Guild Association Teen Cancer Grant (Macpherson, PI);
 Children’s Mercy Hospital
 Hyundai Hope on Wheels {(Stegenga), Fulbright, PI},
 University of Virginia Health System
 University of Virginia School of Nursing (Erickson, PI);
 Virginia Commonwealth University Health System
 Grant # P30 NR011403 Center of Excellence for Biobehavioral Approaches to Symptom Management; NINR, NIH
{(Ameringer), Grap, PI}
 C-SCAT Programming: Intermountain Healthcare Homer Warner Center for Informatics Research
Acknowledgements

More Related Content

What's hot

The impact of abbreviations on patient safety jc
The impact of abbreviations on patient safety jcThe impact of abbreviations on patient safety jc
The impact of abbreviations on patient safety jc
faheta
 
QI Report on HAPUs
QI Report on HAPUsQI Report on HAPUs
QI Report on HAPUs
BrookKing1
 
SARET_mHealthPrivacy_Aug2015
SARET_mHealthPrivacy_Aug2015SARET_mHealthPrivacy_Aug2015
SARET_mHealthPrivacy_Aug2015
Frank Grazioli
 
New Evidence for Patient-Centric Cancer Care
New Evidence for Patient-Centric Cancer CareNew Evidence for Patient-Centric Cancer Care
New Evidence for Patient-Centric Cancer Care
PotentiaMetrics
 
How to Improve the Quality of Medical Decisions
How to Improve the Quality of Medical DecisionsHow to Improve the Quality of Medical Decisions
How to Improve the Quality of Medical Decisions
Informed Medical Decisions Foundation
 
SAC360 Chapter 5 epidemiologic principles and methods
SAC360 Chapter 5 epidemiologic principles and methodsSAC360 Chapter 5 epidemiologic principles and methods
SAC360 Chapter 5 epidemiologic principles and methods
BealCollegeOnline
 
Promoting communication to improve patient care
Promoting communication to improve patient carePromoting communication to improve patient care
Promoting communication to improve patient care
Debbie Fernando
 
Engaging Patients in Antimicrobial Resistance and Stewardship
Engaging Patients in Antimicrobial Resistance and StewardshipEngaging Patients in Antimicrobial Resistance and Stewardship
Engaging Patients in Antimicrobial Resistance and Stewardship
Canadian Patient Safety Institute
 
Top 7 Insights from Years of Observing Real-world Healthcare Communication
Top 7 Insights from Years of Observing Real-world Healthcare Communication Top 7 Insights from Years of Observing Real-world Healthcare Communication
Top 7 Insights from Years of Observing Real-world Healthcare Communication
Ogilvy Health
 
F3 patient engagement-2015philadelphia
F3 patient engagement-2015philadelphiaF3 patient engagement-2015philadelphia
F3 patient engagement-2015philadelphia
Todd Berner MD
 
The Cochrane Library: Web 2.0 & phisical activity
The Cochrane Library:   Web 2.0 & phisical activity The Cochrane Library:   Web 2.0 & phisical activity
The Cochrane Library: Web 2.0 & phisical activity
Giuseppe Fattori
 
DayOne Accelerator 2019/20 shortlisted projects
DayOne Accelerator 2019/20 shortlisted projectsDayOne Accelerator 2019/20 shortlisted projects
DayOne Accelerator 2019/20 shortlisted projects
DayOne
 
Aging Well project - Workshop 1 mobility
Aging Well project - Workshop 1 mobilityAging Well project - Workshop 1 mobility
Aging Well project - Workshop 1 mobility
DayOne
 
Best Practices: Needs Assessment Process, Data/Metric Tracking, and Survivors...
Best Practices: Needs Assessment Process, Data/Metric Tracking, and Survivors...Best Practices: Needs Assessment Process, Data/Metric Tracking, and Survivors...
Best Practices: Needs Assessment Process, Data/Metric Tracking, and Survivors...
Academy of Oncology Nurse Navigators, Inc.
 
NR451_Milestone2_Design_Proposal allen
NR451_Milestone2_Design_Proposal  allenNR451_Milestone2_Design_Proposal  allen
NR451_Milestone2_Design_Proposal allen
Gary Allen
 
Living with HIV/AIDS and use of online support groups [4 1530 Aud Coulson]
Living with HIV/AIDS and use of online support groups [4 1530 Aud  Coulson]Living with HIV/AIDS and use of online support groups [4 1530 Aud  Coulson]
Living with HIV/AIDS and use of online support groups [4 1530 Aud Coulson]
Gunther Eysenbach
 
Vidatak EZ Board
Vidatak EZ BoardVidatak EZ Board
Vidatak EZ Board
IndepMedAssoc
 
Surveillance Systems: Their Role in Identifying Risk and Resilience Factors
Surveillance Systems: Their Role in Identifying Risk and Resilience FactorsSurveillance Systems: Their Role in Identifying Risk and Resilience Factors
Surveillance Systems: Their Role in Identifying Risk and Resilience Factors
ippnw
 
HLST4250Paper (1)
HLST4250Paper (1)HLST4250Paper (1)
HLST4250Paper (1)
Dan Villamayor
 
3 mobile health 4-29-11-psg
3  mobile health 4-29-11-psg3  mobile health 4-29-11-psg
3 mobile health 4-29-11-psg
Mobile Health at Stanford
 

What's hot (20)

The impact of abbreviations on patient safety jc
The impact of abbreviations on patient safety jcThe impact of abbreviations on patient safety jc
The impact of abbreviations on patient safety jc
 
QI Report on HAPUs
QI Report on HAPUsQI Report on HAPUs
QI Report on HAPUs
 
SARET_mHealthPrivacy_Aug2015
SARET_mHealthPrivacy_Aug2015SARET_mHealthPrivacy_Aug2015
SARET_mHealthPrivacy_Aug2015
 
New Evidence for Patient-Centric Cancer Care
New Evidence for Patient-Centric Cancer CareNew Evidence for Patient-Centric Cancer Care
New Evidence for Patient-Centric Cancer Care
 
How to Improve the Quality of Medical Decisions
How to Improve the Quality of Medical DecisionsHow to Improve the Quality of Medical Decisions
How to Improve the Quality of Medical Decisions
 
SAC360 Chapter 5 epidemiologic principles and methods
SAC360 Chapter 5 epidemiologic principles and methodsSAC360 Chapter 5 epidemiologic principles and methods
SAC360 Chapter 5 epidemiologic principles and methods
 
Promoting communication to improve patient care
Promoting communication to improve patient carePromoting communication to improve patient care
Promoting communication to improve patient care
 
Engaging Patients in Antimicrobial Resistance and Stewardship
Engaging Patients in Antimicrobial Resistance and StewardshipEngaging Patients in Antimicrobial Resistance and Stewardship
Engaging Patients in Antimicrobial Resistance and Stewardship
 
Top 7 Insights from Years of Observing Real-world Healthcare Communication
Top 7 Insights from Years of Observing Real-world Healthcare Communication Top 7 Insights from Years of Observing Real-world Healthcare Communication
Top 7 Insights from Years of Observing Real-world Healthcare Communication
 
F3 patient engagement-2015philadelphia
F3 patient engagement-2015philadelphiaF3 patient engagement-2015philadelphia
F3 patient engagement-2015philadelphia
 
The Cochrane Library: Web 2.0 & phisical activity
The Cochrane Library:   Web 2.0 & phisical activity The Cochrane Library:   Web 2.0 & phisical activity
The Cochrane Library: Web 2.0 & phisical activity
 
DayOne Accelerator 2019/20 shortlisted projects
DayOne Accelerator 2019/20 shortlisted projectsDayOne Accelerator 2019/20 shortlisted projects
DayOne Accelerator 2019/20 shortlisted projects
 
Aging Well project - Workshop 1 mobility
Aging Well project - Workshop 1 mobilityAging Well project - Workshop 1 mobility
Aging Well project - Workshop 1 mobility
 
Best Practices: Needs Assessment Process, Data/Metric Tracking, and Survivors...
Best Practices: Needs Assessment Process, Data/Metric Tracking, and Survivors...Best Practices: Needs Assessment Process, Data/Metric Tracking, and Survivors...
Best Practices: Needs Assessment Process, Data/Metric Tracking, and Survivors...
 
NR451_Milestone2_Design_Proposal allen
NR451_Milestone2_Design_Proposal  allenNR451_Milestone2_Design_Proposal  allen
NR451_Milestone2_Design_Proposal allen
 
Living with HIV/AIDS and use of online support groups [4 1530 Aud Coulson]
Living with HIV/AIDS and use of online support groups [4 1530 Aud  Coulson]Living with HIV/AIDS and use of online support groups [4 1530 Aud  Coulson]
Living with HIV/AIDS and use of online support groups [4 1530 Aud Coulson]
 
Vidatak EZ Board
Vidatak EZ BoardVidatak EZ Board
Vidatak EZ Board
 
Surveillance Systems: Their Role in Identifying Risk and Resilience Factors
Surveillance Systems: Their Role in Identifying Risk and Resilience FactorsSurveillance Systems: Their Role in Identifying Risk and Resilience Factors
Surveillance Systems: Their Role in Identifying Risk and Resilience Factors
 
HLST4250Paper (1)
HLST4250Paper (1)HLST4250Paper (1)
HLST4250Paper (1)
 
3 mobile health 4-29-11-psg
3  mobile health 4-29-11-psg3  mobile health 4-29-11-psg
3 mobile health 4-29-11-psg
 

Similar to The Computerized Symptom Capture Tool (C-SCAT)

TickiT: an eHealth solution to the "Don't Ask, Don't Tell" face to face clini...
TickiT: an eHealth solution to the "Don't Ask, Don't Tell" face to face clini...TickiT: an eHealth solution to the "Don't Ask, Don't Tell" face to face clini...
TickiT: an eHealth solution to the "Don't Ask, Don't Tell" face to face clini...
YTH
 
136 Electronic Patient Reported.docx
136 Electronic Patient Reported.docx136 Electronic Patient Reported.docx
136 Electronic Patient Reported.docx
write12
 
Siminoff_et_al-2014-Psycho?Oncology
Siminoff_et_al-2014-Psycho?OncologySiminoff_et_al-2014-Psycho?Oncology
Siminoff_et_al-2014-Psycho?Oncology
Hardin Brotherton
 
MS Trust 2023 MS Wellness apps by dr Agne Straukiene.pptx
MS Trust 2023 MS Wellness apps by dr Agne Straukiene.pptxMS Trust 2023 MS Wellness apps by dr Agne Straukiene.pptx
MS Trust 2023 MS Wellness apps by dr Agne Straukiene.pptx
AgneStraukiene
 
Clearing the Error: Patient Participation in Reducing Diagnostic Error
Clearing the Error: Patient Participation in Reducing Diagnostic ErrorClearing the Error: Patient Participation in Reducing Diagnostic Error
Clearing the Error: Patient Participation in Reducing Diagnostic Error
Jefferson Center
 
Samsha jennings - fallot - cave (2010)
Samsha  jennings - fallot - cave  (2010)Samsha  jennings - fallot - cave  (2010)
Samsha jennings - fallot - cave (2010)
mhcc
 
Psychosocial Distress Management
Psychosocial Distress ManagementPsychosocial Distress Management
Psychosocial Distress Management
Academy of Oncology Nurse Navigators, Inc.
 
E-patients Communities and Chronic Illness
E-patients Communities and Chronic IllnessE-patients Communities and Chronic Illness
E-patients Communities and Chronic Illness
FDASM
 
The ‘prevention revolution’: Implications for health promotion on the ground,...
The ‘prevention revolution’: Implications for health promotion on the ground,...The ‘prevention revolution’: Implications for health promotion on the ground,...
The ‘prevention revolution’: Implications for health promotion on the ground,...
Australian Federation of AIDS Organisations
 
Impact Of Computer Software Appplication On Medication Therapy Adherence
Impact Of Computer Software Appplication On Medication Therapy AdherenceImpact Of Computer Software Appplication On Medication Therapy Adherence
Impact Of Computer Software Appplication On Medication Therapy Adherence
Yayra Nyoagbe
 
A Study on Mood Disorders in Acne among Patients Attending Skin Opd
A Study on Mood Disorders in Acne among Patients Attending Skin OpdA Study on Mood Disorders in Acne among Patients Attending Skin Opd
A Study on Mood Disorders in Acne among Patients Attending Skin Opd
iosrjce
 
TickiT Poster 10-18-16 CRL
TickiT Poster 10-18-16 CRLTickiT Poster 10-18-16 CRL
TickiT Poster 10-18-16 CRL
Alicia Hobbs
 
smith-mckinney-hl101.ppt
smith-mckinney-hl101.pptsmith-mckinney-hl101.ppt
smith-mckinney-hl101.ppt
Lomer2
 
smith-mckinney-hl101.ppt
smith-mckinney-hl101.pptsmith-mckinney-hl101.ppt
smith-mckinney-hl101.ppt
Lomer2
 
Engaging the hard_to_engage_through_innovative_channels
Engaging the hard_to_engage_through_innovative_channelsEngaging the hard_to_engage_through_innovative_channels
Engaging the hard_to_engage_through_innovative_channels
George Van Antwerp
 
Precision prevention and tailored screening public
Precision prevention and tailored screening publicPrecision prevention and tailored screening public
Precision prevention and tailored screening public
Graham Colditz
 
Participation of the population in decisions about their health and in the pr...
Participation of the population in decisions about their health and in the pr...Participation of the population in decisions about their health and in the pr...
Participation of the population in decisions about their health and in the pr...
Pydesalud
 
Melanoma-Publication
Melanoma-PublicationMelanoma-Publication
Melanoma-Publication
Brissan Guardado
 
Nchcmm presentation 10 variables_the research_p_keller_8-2011
Nchcmm presentation 10 variables_the research_p_keller_8-2011Nchcmm presentation 10 variables_the research_p_keller_8-2011
Nchcmm presentation 10 variables_the research_p_keller_8-2011
eileenhaag
 
Jennifer Rayner - 2015 CACHC Conference Presentation
Jennifer Rayner - 2015 CACHC Conference PresentationJennifer Rayner - 2015 CACHC Conference Presentation
Jennifer Rayner - 2015 CACHC Conference Presentation
cachc
 

Similar to The Computerized Symptom Capture Tool (C-SCAT) (20)

TickiT: an eHealth solution to the "Don't Ask, Don't Tell" face to face clini...
TickiT: an eHealth solution to the "Don't Ask, Don't Tell" face to face clini...TickiT: an eHealth solution to the "Don't Ask, Don't Tell" face to face clini...
TickiT: an eHealth solution to the "Don't Ask, Don't Tell" face to face clini...
 
136 Electronic Patient Reported.docx
136 Electronic Patient Reported.docx136 Electronic Patient Reported.docx
136 Electronic Patient Reported.docx
 
Siminoff_et_al-2014-Psycho?Oncology
Siminoff_et_al-2014-Psycho?OncologySiminoff_et_al-2014-Psycho?Oncology
Siminoff_et_al-2014-Psycho?Oncology
 
MS Trust 2023 MS Wellness apps by dr Agne Straukiene.pptx
MS Trust 2023 MS Wellness apps by dr Agne Straukiene.pptxMS Trust 2023 MS Wellness apps by dr Agne Straukiene.pptx
MS Trust 2023 MS Wellness apps by dr Agne Straukiene.pptx
 
Clearing the Error: Patient Participation in Reducing Diagnostic Error
Clearing the Error: Patient Participation in Reducing Diagnostic ErrorClearing the Error: Patient Participation in Reducing Diagnostic Error
Clearing the Error: Patient Participation in Reducing Diagnostic Error
 
Samsha jennings - fallot - cave (2010)
Samsha  jennings - fallot - cave  (2010)Samsha  jennings - fallot - cave  (2010)
Samsha jennings - fallot - cave (2010)
 
Psychosocial Distress Management
Psychosocial Distress ManagementPsychosocial Distress Management
Psychosocial Distress Management
 
E-patients Communities and Chronic Illness
E-patients Communities and Chronic IllnessE-patients Communities and Chronic Illness
E-patients Communities and Chronic Illness
 
The ‘prevention revolution’: Implications for health promotion on the ground,...
The ‘prevention revolution’: Implications for health promotion on the ground,...The ‘prevention revolution’: Implications for health promotion on the ground,...
The ‘prevention revolution’: Implications for health promotion on the ground,...
 
Impact Of Computer Software Appplication On Medication Therapy Adherence
Impact Of Computer Software Appplication On Medication Therapy AdherenceImpact Of Computer Software Appplication On Medication Therapy Adherence
Impact Of Computer Software Appplication On Medication Therapy Adherence
 
A Study on Mood Disorders in Acne among Patients Attending Skin Opd
A Study on Mood Disorders in Acne among Patients Attending Skin OpdA Study on Mood Disorders in Acne among Patients Attending Skin Opd
A Study on Mood Disorders in Acne among Patients Attending Skin Opd
 
TickiT Poster 10-18-16 CRL
TickiT Poster 10-18-16 CRLTickiT Poster 10-18-16 CRL
TickiT Poster 10-18-16 CRL
 
smith-mckinney-hl101.ppt
smith-mckinney-hl101.pptsmith-mckinney-hl101.ppt
smith-mckinney-hl101.ppt
 
smith-mckinney-hl101.ppt
smith-mckinney-hl101.pptsmith-mckinney-hl101.ppt
smith-mckinney-hl101.ppt
 
Engaging the hard_to_engage_through_innovative_channels
Engaging the hard_to_engage_through_innovative_channelsEngaging the hard_to_engage_through_innovative_channels
Engaging the hard_to_engage_through_innovative_channels
 
Precision prevention and tailored screening public
Precision prevention and tailored screening publicPrecision prevention and tailored screening public
Precision prevention and tailored screening public
 
Participation of the population in decisions about their health and in the pr...
Participation of the population in decisions about their health and in the pr...Participation of the population in decisions about their health and in the pr...
Participation of the population in decisions about their health and in the pr...
 
Melanoma-Publication
Melanoma-PublicationMelanoma-Publication
Melanoma-Publication
 
Nchcmm presentation 10 variables_the research_p_keller_8-2011
Nchcmm presentation 10 variables_the research_p_keller_8-2011Nchcmm presentation 10 variables_the research_p_keller_8-2011
Nchcmm presentation 10 variables_the research_p_keller_8-2011
 
Jennifer Rayner - 2015 CACHC Conference Presentation
Jennifer Rayner - 2015 CACHC Conference PresentationJennifer Rayner - 2015 CACHC Conference Presentation
Jennifer Rayner - 2015 CACHC Conference Presentation
 

More from dylanturner22

Robust Methods for Health-related Quality-of-life Assessment
Robust Methods for Health-related Quality-of-life AssessmentRobust Methods for Health-related Quality-of-life Assessment
Robust Methods for Health-related Quality-of-life Assessment
dylanturner22
 
Patient Reported Outcomes (PROs) in Care Managed Patients: Potential and Chal...
Patient Reported Outcomes (PROs) in Care Managed Patients: Potential and Chal...Patient Reported Outcomes (PROs) in Care Managed Patients: Potential and Chal...
Patient Reported Outcomes (PROs) in Care Managed Patients: Potential and Chal...
dylanturner22
 
Intermountain Diabetes Prevention Program:
Intermountain Diabetes Prevention Program:Intermountain Diabetes Prevention Program:
Intermountain Diabetes Prevention Program:
dylanturner22
 
The University of Utah Center for Clinical and Translational Science (CCTS)
The University of Utah Center for Clinical and Translational Science (CCTS)The University of Utah Center for Clinical and Translational Science (CCTS)
The University of Utah Center for Clinical and Translational Science (CCTS)
dylanturner22
 
Psychological Foundation of Clinical Decision-Support
Psychological Foundation of Clinical Decision-SupportPsychological Foundation of Clinical Decision-Support
Psychological Foundation of Clinical Decision-Support
dylanturner22
 
Bisphosphonates for Fracture Prevention in Males: A Systematic Review and Met...
Bisphosphonates for Fracture Prevention in Males: A Systematic Review and Met...Bisphosphonates for Fracture Prevention in Males: A Systematic Review and Met...
Bisphosphonates for Fracture Prevention in Males: A Systematic Review and Met...
dylanturner22
 
Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...
Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...
Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...
dylanturner22
 
Pros In Clinical Care
Pros In Clinical CarePros In Clinical Care
Pros In Clinical Care
dylanturner22
 
Robust Methods for Health-related Quality-of-life Assessment
Robust Methods for Health-related  Quality-of-life AssessmentRobust Methods for Health-related  Quality-of-life Assessment
Robust Methods for Health-related Quality-of-life Assessment
dylanturner22
 
Agreement between Claims-based and Self-reported Adherence Measures in Patien...
Agreement between Claims-based and Self-reported Adherence Measures in Patien...Agreement between Claims-based and Self-reported Adherence Measures in Patien...
Agreement between Claims-based and Self-reported Adherence Measures in Patien...
dylanturner22
 
Associations of the timing of physical therapy utilization and subsequent he...
Associations of the timing of physical  therapy utilization and subsequent he...Associations of the timing of physical  therapy utilization and subsequent he...
Associations of the timing of physical therapy utilization and subsequent he...
dylanturner22
 
The Medicaid and CHIP Payment and Access Commission (MACPAC)
The Medicaid and CHIP Payment and Access Commission (MACPAC)The Medicaid and CHIP Payment and Access Commission (MACPAC)
The Medicaid and CHIP Payment and Access Commission (MACPAC)
dylanturner22
 
TREATMENT AND LONG-TERM COSTS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
TREATMENT AND LONG-TERM COSTS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIATREATMENT AND LONG-TERM COSTS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
TREATMENT AND LONG-TERM COSTS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
dylanturner22
 
Body Mass Index of Adolescent and Adult Survivors of Pediatric Acute Lymphobl...
Body Mass Index of Adolescent and Adult Survivors of Pediatric Acute Lymphobl...Body Mass Index of Adolescent and Adult Survivors of Pediatric Acute Lymphobl...
Body Mass Index of Adolescent and Adult Survivors of Pediatric Acute Lymphobl...
dylanturner22
 
Low 3-dose completion and missed opportunities for the HPV vaccine in Utah
Low 3-dose completion and missed opportunities for the HPV vaccine in UtahLow 3-dose completion and missed opportunities for the HPV vaccine in Utah
Low 3-dose completion and missed opportunities for the HPV vaccine in Utah
dylanturner22
 
Financial Burden of Pediatric Cancer for Patients and their Families
Financial Burden of Pediatric Cancer for Patients and their FamiliesFinancial Burden of Pediatric Cancer for Patients and their Families
Financial Burden of Pediatric Cancer for Patients and their Families
dylanturner22
 

More from dylanturner22 (16)

Robust Methods for Health-related Quality-of-life Assessment
Robust Methods for Health-related Quality-of-life AssessmentRobust Methods for Health-related Quality-of-life Assessment
Robust Methods for Health-related Quality-of-life Assessment
 
Patient Reported Outcomes (PROs) in Care Managed Patients: Potential and Chal...
Patient Reported Outcomes (PROs) in Care Managed Patients: Potential and Chal...Patient Reported Outcomes (PROs) in Care Managed Patients: Potential and Chal...
Patient Reported Outcomes (PROs) in Care Managed Patients: Potential and Chal...
 
Intermountain Diabetes Prevention Program:
Intermountain Diabetes Prevention Program:Intermountain Diabetes Prevention Program:
Intermountain Diabetes Prevention Program:
 
The University of Utah Center for Clinical and Translational Science (CCTS)
The University of Utah Center for Clinical and Translational Science (CCTS)The University of Utah Center for Clinical and Translational Science (CCTS)
The University of Utah Center for Clinical and Translational Science (CCTS)
 
Psychological Foundation of Clinical Decision-Support
Psychological Foundation of Clinical Decision-SupportPsychological Foundation of Clinical Decision-Support
Psychological Foundation of Clinical Decision-Support
 
Bisphosphonates for Fracture Prevention in Males: A Systematic Review and Met...
Bisphosphonates for Fracture Prevention in Males: A Systematic Review and Met...Bisphosphonates for Fracture Prevention in Males: A Systematic Review and Met...
Bisphosphonates for Fracture Prevention in Males: A Systematic Review and Met...
 
Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...
Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...
Risk of Hypoglycemia Associated with Different Insulin Delivery Systems in Ty...
 
Pros In Clinical Care
Pros In Clinical CarePros In Clinical Care
Pros In Clinical Care
 
Robust Methods for Health-related Quality-of-life Assessment
Robust Methods for Health-related  Quality-of-life AssessmentRobust Methods for Health-related  Quality-of-life Assessment
Robust Methods for Health-related Quality-of-life Assessment
 
Agreement between Claims-based and Self-reported Adherence Measures in Patien...
Agreement between Claims-based and Self-reported Adherence Measures in Patien...Agreement between Claims-based and Self-reported Adherence Measures in Patien...
Agreement between Claims-based and Self-reported Adherence Measures in Patien...
 
Associations of the timing of physical therapy utilization and subsequent he...
Associations of the timing of physical  therapy utilization and subsequent he...Associations of the timing of physical  therapy utilization and subsequent he...
Associations of the timing of physical therapy utilization and subsequent he...
 
The Medicaid and CHIP Payment and Access Commission (MACPAC)
The Medicaid and CHIP Payment and Access Commission (MACPAC)The Medicaid and CHIP Payment and Access Commission (MACPAC)
The Medicaid and CHIP Payment and Access Commission (MACPAC)
 
TREATMENT AND LONG-TERM COSTS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
TREATMENT AND LONG-TERM COSTS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIATREATMENT AND LONG-TERM COSTS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
TREATMENT AND LONG-TERM COSTS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
 
Body Mass Index of Adolescent and Adult Survivors of Pediatric Acute Lymphobl...
Body Mass Index of Adolescent and Adult Survivors of Pediatric Acute Lymphobl...Body Mass Index of Adolescent and Adult Survivors of Pediatric Acute Lymphobl...
Body Mass Index of Adolescent and Adult Survivors of Pediatric Acute Lymphobl...
 
Low 3-dose completion and missed opportunities for the HPV vaccine in Utah
Low 3-dose completion and missed opportunities for the HPV vaccine in UtahLow 3-dose completion and missed opportunities for the HPV vaccine in Utah
Low 3-dose completion and missed opportunities for the HPV vaccine in Utah
 
Financial Burden of Pediatric Cancer for Patients and their Families
Financial Burden of Pediatric Cancer for Patients and their FamiliesFinancial Burden of Pediatric Cancer for Patients and their Families
Financial Burden of Pediatric Cancer for Patients and their Families
 

Recently uploaded

Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
rightmanforbloodline
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 

Recently uploaded (20)

Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 

The Computerized Symptom Capture Tool (C-SCAT)

  • 1. The Computerized Symptom Capture Tool (C-SCAT): A Novel Approach to Exploring Symptoms and Symptom Clusters In Adolescents and Young Adults with Cancer Lauri Linder, PhD, APRN, CPON Catherine Fiona Macpherson, PhD, RN, CPON University of Utah College of Nursing Seattle Children’s Hospital Primary Children’s Hospital University of Washington Kristin Stegenga, PhD, RN, CPON Suzanne Ameringer, PhD, RN Children’s Mercy Hospital Virginia Commonwealth University Jeanne Erickson, PhD, RN, AOCN Pamela Hinds, PhD, RN, FAAN University of Virginia Children’s National Medical Center Nancy Fugate Woods, PhD, RN, FAAN University of Washington
  • 2. Speaker Disclosure Statement  The authors have no financial relationships to disclose
  • 3. Adolescents and Young Adults with Cancer  Approximately 70,000 adolescents and young adults newly diagnosed each year (National Cancer Institute, 2012)  15 to 39 years of age (National Cancer Institute, 2012)  Cancer types distinct from older and younger age groups  Developmental characteristics  Adolescents physically maturing, achieving independence from parents, and making significant decisions related to education and relationships  Young adults achieving financial, residential, and emotional independence; assuming adult roles  Both groups with access to electronic media and often prefer computers to paper for completing health surveys
  • 4. Defining Symptom …  “… a subjective experience reflecting changes in the biopsychosocial functioning, sensations, or cognition of an individual.” (Harver & Mahler, 1990)  “The gold standard for the study of symptoms is based on the perception of the individual experiencing the symptom and his/her self-report.” (Dodd et al., 2001)
  • 5. Symptoms in Adolescents and Young Adults with Cancer  Adolescents and young adults receiving treatment for cancer report up to 12 concurrent symptoms (Baggott et al., 2010; Collins et al., 2000; Enskar & von Essen 2008; Hedstrom et al., 2006; Hedstrom et al., 2004; Yeh et al., 2009; Zhukovsky et al., 2009)  Number of symptoms and associated symptom distress greatest while receiving treatment (Collins et al., 2000; Enskar & von Essen, 2007; Hinds et al., 2009)  Severity of symptoms influences decision-making related to treatment (Docherty, Sandelowski, & Preisser, 2006; Woodgate, Degner, & Yanofsky, 2003)
  • 6. What is a Symptom Cluster?  Two or more symptoms that are related to each other and that occur together (Kim et al., 2005)  Relationships between the symptoms are associative and not necessarily causal  May share a common etiology or underlying mechanism (Barsevick, 2007) Hockenberry & Hooke, 2007
  • 7. Why Study Symptom Clusters vs. Individual Symptoms?  Identifying and understanding symptom clusters…  Informs effective symptom management interventions (Kim et al., 2005; Miaskowski, Dodd, & Lee, 2004)  May lead to prevention and relief of the complex and/or synergistic effects of multiple symptoms on patient outcomes (Kim et al., 2005; Miaskowski, Dodd, & Lee, 2004)
  • 8. Symptom Clusters in Adolescents and Young Adults with Cancer  Symptom cluster research is limited  Adolescents frequently included in study samples with school-age children  Young adults frequently included in study samples with older adults  Research exploring whether and how AYAs cluster their symptoms or the meaning they attach to their symptoms and symptom clusters is limited
  • 9. Approaches to Symptom Cluster Research  Dominant approaches for studying symptom clusters include multivariate statistical methods to identify clusters from patient-reported symptoms (Baggott et al., 2012; Hockenberry et al., 2011; Miaskowski et al., 2006; Yeh et al., 2008)  Symptom cluster heuristics is an alternate methodological approach that explores patients' interpretation and meaning of the symptom cluster experience
  • 10. Aims  Examine feasibility and acceptability of using the Computerized Symptom Capture Assessment Tool (C-SCAT) for exploring symptoms and symptom clusters in AYAs with cancer  Describe the symptoms and symptom clusters from the perspectives of AYA with cancer
  • 11. Participants  72 AYAs receiving myelosuppressive chemotherapy  40 adolescents (median 15 years; range 13-18)  32 young adults (median 21.5 years; range 19-29)  Median of 3 months since diagnosis (range 1 – 156)  57% male; 79% White/Non- Hispanic ALL AML Hodgkin lymphoma Non- Hodgkin lymphoma Sarcoma Brain tumor Other solid tumor
  • 12. Study Procedure  Participants completed the C-SCAT app with a study team member present 24 to 96 hours after initiating a chemotherapy cycle  Participants completed a questionnaire delivered via the iPad addressing the app’s acceptability  Ethical considerations  IRB approval granted from the five data collection sites  Parental permission and participant assent obtained from participants 13 – 17 years  Informed consent obtained from participants 18 years and older
  • 13. Goals of the C-SCAT  Integrate innovative and developmentally meaningful technology in a novel approach to study symptoms and symptom clusters in AYAs with cancer  Elicit interpretive guidance from adolescents as to the meaning of their symptoms and symptom clusters by allowing the AYAs to identify:  Symptoms, possible causes, alleviating/exacerbating factors, attempted self-management strategies, and effects of symptoms on daily activities  Perceived causal and temporal relationships among symptoms  Names for symptom clusters and key symptoms within clusters
  • 14. Steps to C-SCAT Completion  Drag and drop symptoms experienced in past 24 hours into designated area of screen  Identify symptom cause, characteristics, attempted self-management, and effect on daily activities  Draw lines and arrows to indicate relationships between symptoms  Draw boxes around groups of related symptoms  Identify priority symptom within each group
  • 15. Results - Feasibility  100% fully completed C-SCAT within 24 – 96 hours of starting a new chemotherapy cycle  Mean of 25 minutes to complete the app (SD=17; range 2 – 83)  70% indicated final image was accurate representation of their symptom experience  3 cases of technical difficulties with lost/missing data  Participants completed app with minimal questions for clarification
  • 16. Results - Acceptability 0 10 20 30 40 50 60 70 80 90 100 Acceptable amount of time to complete app Bored while completing the app App asked important questions Easy to type or draw in the app App instructions easy to follow App questions clear or very clear Percent of respondents in agreement
  • 17. Results - Acceptability  Increased self-awareness of symptom experience  Appreciation for ability to create pictorial representation of symptoms  Preference for using technology over paper and pencil instruments  Familiarity with technology  Novelty of the application  Appreciation of speed and flexibility for editing responses  Ease of using touchscreens rather than writing responses  Suggestions for improvement  Additional symptoms  Focused questions  More engaging color graphics
  • 18. Results - Acceptability  How did it feel to think about your symptoms while completing the app?  “It made me understand my own symptoms a little better, actually”  “It was fine. It certainly didn’t make my symptoms worse.”  “It was kind of hard because I’ve had so many different symptoms that I can’t remember if they happened within the time period you asked about.”  “Not good to [be] reminded [of] all [the] bad things.”  “Painful”  “Sucky”
  • 19. Results - Acceptability  83% expressed a preference for the app vs a paper- and-pencil version  “Doing it on paper would be boring and a lot more work to do. And most people my age are lazy and wouldn't want to do it.”  “It's incredible technology, there's nothing exciting about paper”  “No erasing, and the iPad had autocorrect, and also I’m used to typing on touchscreens.”  “Because of my hands and neuropathy easier to do on iPad”
  • 20. Results – Symptoms & Symptom Clusters  Median of 8 symptoms  (range 1-21)  Most frequently reported individual symptoms  Nausea, lack of appetite, lack of energy, feeling drowsy  65% of AYAs identified symptom clusters  (median 2 clusters; range 1-4)  Cluster name examples  “chemo effects,” “not fun treatment,” “troublesum (sic),” “crap”
  • 21. Future Directions  Refinements to the C-SCAT app  Additional symptoms, more engaging graphics, more focused questions  Address technical difficulties  Use the C-SCAT to facilitate a personalized approach to symptom management as a mobile health resource  Enhance adolescent-healthcare provider communication  Prioritize symptom management interventions
  • 22. Conclusion  C-SCAT shifts paradigm of symptom and symptom cluster assessment from deductive to inductive approach that considers how individuals interpret and give meaning to symptoms  C-SCAT demonstrated:  feasibility  acceptability  capacity to generate rich data reflecting the individual’s experience  C-SCAT has potential for use in clinical care to foster patient- provider communication about complex symptom experiences to facilitate symptom management:  for AYAs with cancer  across other age and disease groups
  • 23.  Funding for adolescents at Primary Children’s Hospital, Seattle Children’s Hospital, and Children’s Mercy Hospital  St. Baldrick’s Foundation Supportive Care Grant 2011-2013 (Linder, PI)  Funding for young adults:  Primary Children’s Hospital  University of Utah College of Nursing Faculty Research Grant (Linder, PI);  Seattle Children’s Hospital  Seattle Children’s Guild Association Teen Cancer Grant (Macpherson, PI);  Children’s Mercy Hospital  Hyundai Hope on Wheels {(Stegenga), Fulbright, PI},  University of Virginia Health System  University of Virginia School of Nursing (Erickson, PI);  Virginia Commonwealth University Health System  Grant # P30 NR011403 Center of Excellence for Biobehavioral Approaches to Symptom Management; NINR, NIH {(Ameringer), Grap, PI}  C-SCAT Programming: Intermountain Healthcare Homer Warner Center for Informatics Research Acknowledgements